These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. Saussy DL; Mais DE; Knapp DR; Halushka PV Circulation; 1985 Dec; 72(6):1202-7. PubMed ID: 2998641 [TBL] [Abstract][Full Text] [Related]
11. Acute reversible reduction of PGI2 platelet receptors after iloprost infusion in man. Modesti PA; Fortini A; Poggesi L; Boddi M; Abbate R; Gensini GF Thromb Res; 1987 Dec; 48(6):663-9. PubMed ID: 2448896 [TBL] [Abstract][Full Text] [Related]
12. Refractoriness of platelets to prostaglandins after infusion in rabbits. Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353 [TBL] [Abstract][Full Text] [Related]
13. Evidence for high affinity prostacyclin binding sites in vascular tissue: radioligand studies with a chemically stable analogue. Rücker W; Schrör K Biochem Pharmacol; 1983 Aug; 32(16):2405-10. PubMed ID: 6193794 [TBL] [Abstract][Full Text] [Related]
14. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets. Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968 [TBL] [Abstract][Full Text] [Related]
15. The single prostacyclin receptor of gel-filtered platelets provides a correlation with antiaggregatory potency of PGI2 mimics. Eggerman TL; Hartzell CJ; Selfe S; Andersen NH Thromb Res; 1987 Mar; 45(5):645-59. PubMed ID: 3296302 [TBL] [Abstract][Full Text] [Related]
16. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets. Miller OV; Gorman RR J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643 [TBL] [Abstract][Full Text] [Related]